Nurses’ Knowledge, Attitudes and Practices on the Management of Clostridioides difficile Infection: A Cross-Sectional Study
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
4.1. Study Design and Setting
4.2. Questionnaire Development
4.3. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Czepiel, J.; Dróżdż, M.; Pituch, H.; Kuijper, E.J.; Perucki, W.; Mielimonka, A.; Goldman, S.; Wultańska, D.; Garlicki, A.; Biesiada, G. Clostridium difficile Infection: Review. Eur. J. Clin. Microbiol. Infect. Dis. 2019, 38, 1211–1221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Magill, S.S.; Edwards, J.R.; Bamberg, W.; Beldavs, Z.G.; Dumyati, G.; Kainer, M.A.; Lynfield, R.; Maloney, M.; McAllister-Hollod, L.; Nadle, J.; et al. Multistate Point-Prevalence Survey of Health Care-Associated Infections. N. Engl. J. Med. 2014, 370, 1198–1208. [Google Scholar] [CrossRef] [Green Version]
- Zimlichman, E.; Henderson, D.; Tamir, O.; Franz, C.; Song, P.; Yamin, C.K.; Keohane, C.; Denham, C.R.; Bates, D.W. Health Care–Associated Infections: A Meta-Analysis of Costs and Financial Impact on the US Health Care System. JAMA Intern. Med. 2013, 173, 2039. [Google Scholar] [CrossRef] [PubMed]
- Finn, E.; Andersson, F.L.; Madin-Warburton, M. Burden of Clostridioides Difficile Infection (CDI)—A Systematic Review of the Epidemiology of Primary and Recurrent CDI. BMC Infect. Dis. 2021, 21, 456. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention (U.S.). Antibiotic Resistance Threats in the United States, 2019; Centers for Disease Control and Prevention (U.S.): Atlanta, GA, USA, 2019.
- Davies, K.A.; Longshaw, C.M.; Davis, G.L.; Bouza, E.; Barbut, F.; Barna, Z.; Delmée, M.; Fitzpatrick, F.; Ivanova, K.; Kuijper, E.; et al. Underdiagnosis of Clostridium difficile across Europe: The European, Multicentre, Prospective, Biannual, Point-Prevalence Study of Clostridium difficile Infection in Hospitalised Patients with Diarrhoea (EUCLID). Lancet Infect. Dis. 2014, 14, 1208–1219. [Google Scholar] [CrossRef] [PubMed]
- Winston, J.A.; Theriot, C.M. Impact of Microbial Derived Secondary Bile Acids on Colonization Resistance against Clostridium difficile in the Gastrointestinal Tract. Anaerobe 2016, 41, 44–50. [Google Scholar] [CrossRef] [Green Version]
- Mullish, B.H.; Williams, H.R. Clostridium difficile Infection and Antibiotic-Associated Diarrhoea. Clin. Med. 2018, 18, 237–241. [Google Scholar] [CrossRef] [Green Version]
- Lessa, F.C.; Gould, C.V.; McDonald, L.C. Current Status of Clostridium difficile Infection Epidemiology. Clin. Infect. Dis. 2012, 55 (Suppl 2), S65–S70. [Google Scholar] [CrossRef] [Green Version]
- Loizzi, M.; De Palma, A.; Pagliarulo, V.; Loizzi, D.; Sollitto, F. Pulmonary Infections of Surgical Interest in Childhood. Thorac. Surg. Clin. 2012, 22, 387–401. [Google Scholar] [CrossRef]
- Nitzan, O.; Elias, M.; Chazan, B.; Raz, R.; Saliba, W. Clostridium difficile and Inflammatory Bowel Disease: Role in Pathogenesis and Implications in Treatment. World J. Gastroenterol. WJG 2013, 19, 7577–7585. [Google Scholar] [CrossRef]
- Kim, S.C.; Seo, M.Y.; Lee, J.Y.; Kim, K.T.; Cho, E.; Kim, M.-G.; Jo, S.-K.; Cho, W.-Y.; Kim, H.-K. Advanced Chronic Kidney Disease: A Strong Risk Factor for Clostridium difficile Infection. Korean J. Intern. Med. 2016, 31, 125–133. [Google Scholar] [CrossRef] [PubMed]
- Dubberke, E.R.; Reske, K.A.; Noble-Wang, J.; Thompson, A.; Killgore, G.; Mayfield, J.; Camins, B.; Woeltje, K.; McDonald, J.R.; McDonald, L.C.; et al. Prevalence of Clostridium difficile Environmental Contamination and Strain Variability in Multiple Health Care Facilities. Am. J. Infect. Control 2007, 35, 315–318. [Google Scholar] [CrossRef] [PubMed]
- Leffler, D.A.; Lamont, J.T. Clostridium difficile Infection. N. Engl. J. Med. 2015, 372, 1539–1548. [Google Scholar] [CrossRef] [Green Version]
- Furuya-Kanamori, L.; Marquess, J.; Yakob, L.; Riley, T.V.; Paterson, D.L.; Foster, N.F.; Huber, C.A.; Clements, A.C.A. Asymptomatic Clostridium difficile Colonization: Epidemiology and Clinical Implications. BMC Infect. Dis. 2015, 15, 516. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jump, R.L.P.; Donskey, C.J. Clostridium difficile in the Long-Term Care Facility: Prevention and Management. Curr. Geriatr. Rep. 2015, 4, 60–69. [Google Scholar] [CrossRef] [PubMed]
- Johnson, S.; Gerding, D.N.; Olson, M.M.; Weiler, M.D.; Hughes, R.A.; Clabots, C.R.; Peterson, L.R. Prospective, Controlled Study of Vinyl Glove Use to Interrupt Clostridium difficile Nosocomial Transmission. Am. J. Med. 1990, 88, 137–140. [Google Scholar] [CrossRef]
- Lim, S.C.; Knight, D.R.; Riley, T.V. Clostridium difficile and One Health. Clin. Microbiol. Infect. 2020, 26, 857–863. [Google Scholar] [CrossRef]
- Carter, E.J.; Greendyke, W.G.; Furuya, E.Y.; Srinivasan, A.; Shelley, A.N.; Bothra, A.; Saiman, L.; Larson, E.L. Exploring the Nurses’ Role in Antibiotic Stewardship: A Multisite Qualitative Study of Nurses and Infection Preventionists. Am. J. Infect. Control 2018, 46, 492–497. [Google Scholar] [CrossRef]
- European Centre for Disease Prevention and Control; World Health Organization. Antimicrobial Resistance Surveillance in Europe: 2022: 2020 Data; Publications Office: Luxembourg, 2022.
- Bischoff, W.E.; Reynolds, T.M.; Sessler, C.N.; Edmond, M.B.; Wenzel, R.P. Handwashing Compliance by Health Care Workers: The Impact of Introducing an Accessible, Alcohol-Based Hand Antiseptic. Arch. Intern. Med. 2000, 160, 1017–1021. [Google Scholar] [CrossRef]
- Jabbar, U.; Leischner, J.; Kasper, D.; Gerber, R.; Sambol, S.P.; Parada, J.P.; Johnson, S.; Gerding, D.N. Effectiveness of Alcohol-Based Hand Rubs for Removal of Clostridium difficile Spores from Hands. Infect. Control. Hosp. Epidemiol. 2010, 31, 565–570. [Google Scholar] [CrossRef]
- Aroori, S.; Blencowe, N.; Pye, G.; West, R. Clostridium difficile: How Much Do Hospital Staff Know about It? Ann. R. Coll. Surg. Engl. 2009, 91, 464–469. [Google Scholar] [CrossRef] [Green Version]
- Legenza, L.; Barnett, S.; Rose, W.; Safdar, N.; Emmerling, T.; Peh, K.H.; Coetzee, R. Clostridium difficile Infection Perceptions and Practices: A Multicenter Qualitative Study in South Africa. Antimicrob. Resist. Infect. Control 2018, 7, 125. [Google Scholar] [CrossRef] [PubMed]
- Finnimore, K.; Smyth, W.; Carrucan, J.; Nagle, C. Nurses’ Knowledge, Practices and Perceptions Regarding Clostridioides Difficile: Survey Results. Infect. Dis. Health 2022, 28, 39–46. [Google Scholar] [CrossRef] [PubMed]
- Review on Antimicrobial Resistance. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Available online: https://amr-review.org/ (accessed on 2 December 2022).
- Segala, F.V.; Bavaro, D.F.; Di Gennaro, F.; Salvati, F.; Marotta, C.; Saracino, A.; Murri, R.; Fantoni, M. Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review. Viruses 2021, 13, 2110. [Google Scholar] [CrossRef] [PubMed]
- Peng, Z.; Jin, D.; Kim, H.B.; Stratton, C.W.; Wu, B.; Tang, Y.-W.; Sun, X. Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing. J. Clin. Microbiol. 2017, 55, 1998–2008. [Google Scholar] [CrossRef] [Green Version]
- Carignan, A.; Allard, C.; Pépin, J.; Cossette, B.; Nault, V.; Valiquette, L. Risk of Clostridium difficile Infection after Perioperative Antibacterial Prophylaxis before and during an Outbreak of Infection Due to a Hypervirulent Strain. Clin. Infect. Dis. 2008, 46, 1838–1843. [Google Scholar] [CrossRef] [Green Version]
- Sartelli, M.; Di Bella, S.; McFarland, L.V.; Khanna, S.; Furuya-Kanamori, L.; Abuzeid, N.; Abu-Zidan, F.M.; Ansaloni, L.; Augustin, G.; Bala, M.; et al. 2019 Update of the WSES Guidelines for Management of Clostridioides (Clostridium) Difficile Infection in Surgical Patients. World J. Emerg. Surg. 2019, 14, 8. [Google Scholar] [CrossRef]
- van Prehn, J.; Reigadas, E.; Vogelzang, E.H.; Bouza, E.; Hristea, A.; Guery, B.; Krutova, M.; Norén, T.; Allerberger, F.; Coia, J.; et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 Update on the Treatment Guidance Document for Clostridioides Difficile Infection in Adults. Clin. Microbiol. Infect. 2021, 27, S1–S21. [Google Scholar] [CrossRef]
- McDonald, L.C.; Gerding, D.N.; Johnson, S.; Bakken, J.S.; Carroll, K.C.; Coffin, S.E.; Dubberke, E.R.; Garey, K.W.; Gould, C.V.; Kelly, C.; et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin. Infect. Dis. 2018, 66, e1–e48. [Google Scholar] [CrossRef]
- Goglio, A. Prevenzione e Controllo Delle Infezioni da Clostridium difficile, Febbraio 2011. Available online: https://www.simpios.eu/2016/12/05/prevenzione-e-controllo-delle-infezioni-da-clostridium-difficile/ (accessed on 2 December 2022).
Characteristic | Total Number (%) |
---|---|
Female | 150 (75) |
Local Health Service | |
A | 19 (9.5) |
B | 95 (47.5) |
C | 28 (14) |
D | 58 (29) |
Ward type | |
Long-term care | 22 (11) |
Medicine | 178 (89) |
Work experience (years) | |
<1 | 28 (14) |
1–5 | 44 (22) |
6–10 | 27 (13.5) |
11–14 | 27 (13.5) |
16–20 | 23 (11.5) |
>20 | 51 (25.5) |
Educational level | |
Nursing School Degree | 42 (21) |
Nursing University Degree | 31 (15.5) |
Graduate | 125 (62) |
Master’s Degree | 2 (1) |
Item | Total Number (%) |
---|---|
1. Have you heard of C. difficile? | |
Yes | 195 (97.5) |
No | 5 (2.5) |
2. C. difficile is | |
Virus | 7 (3.5) |
Bacterium | 174 (87) |
Mycobacterium | 17 (8.5) |
3. What are the main symptoms of CDI? | |
Watery diarrhea and dyspnea | 14 (7) |
Fever, vomiting | 2 (1) |
Watery diarrhea and abdominal pain | 184 (92) |
4. What is the transmission route of CDI? | |
Fecal-oral route and contact | 188 (94) |
Airborne | 0 (0) |
Airborne and contact | 12 (6) |
5. What are the main risk factors for CDI? | |
Old age, improper use of antibiotics, immunosuppression | 22 (11) |
Genetic predisposition, old age, improper use of antibiotics, immunosuppression | 7 (3.5) |
Long hospitalization, old age, improper use of antibiotics, immunosuppression | 171 (85.5) |
6. Diagnosis of CDI requires the use of | |
Rectal swab | 40 (20) |
Test tube for fecal sample | 135 (67.5) |
Test tube for fecal occult blood | 25 (12.5) |
7. When is stool sampling necessary for Clostridium difficile? | |
If the patient has several episodes of diarrhea If the patient has foul-smelling formed stools If the patient has melena | 186 (93) 12 (6) 2 (1) |
8. What is the correct hand washing method to prevent CDI? | |
Water and soap | 57 (28.5) |
Alcohol solution Soap with chlorhexidine | 35 (17.5) 108 (54) |
9. Environmental disinfection must be performed with | |
Alcohol-based products | 64 (32) |
UV rays | 4 (2) |
Sporicidal agents | 132 (66) |
10. How often should high-touch surfaces in CDI patients’ rooms be disinfected? | |
Every day | 82 (41) |
Several times during the day | 32 (16) |
Only when the room is cleared | 86 (43) |
11. What is the correct PPE to use with patients with CDI? | |
Gloves and gowns | 154 (77) |
Gloves and mask | 43 (21.5) |
Gloves and overshoes | 3 (1.5) |
12. What are the precautions to consider in a suspected case of CDI? | |
Use PPE | 34 (17) |
Isolate the patient and use PPE | 165 (82.5) |
Isolate the patient only if you have not started pharmacological therapy | 1 (0.5) |
13. How should you act if more cases of CDI occur? | |
Cohort patients, isolate and use PPE | 138 (69) |
Use PPE and start pharmacological therapy | 30 (15) |
Isolate only patients with suspected CDI | 32 (16) |
14. When can isolation measures be discontinued in a patient being treated for C. difficile diarrhea? | |
48 h after the last diarrheal discharge | 31 (15.5) |
After repeating the confirmation of healing test | 166 (83) |
After a week of isolation | 3 (1.5) |
15. What is the first choice for CDI treatment? | |
Oral vancomycin | 157 (78.5) |
Oral metronidazole | 12 (6) |
Intravenous metronidazole | 31 (15.5) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Comparcini, D.; Simonetti, V.; Segala, F.V.; Di Gennaro, F.; Bavaro, D.F.; Pompeo, M.A.; Saracino, A.; Cicolini, G. Nurses’ Knowledge, Attitudes and Practices on the Management of Clostridioides difficile Infection: A Cross-Sectional Study. Antibiotics 2023, 12, 529. https://doi.org/10.3390/antibiotics12030529
Comparcini D, Simonetti V, Segala FV, Di Gennaro F, Bavaro DF, Pompeo MA, Saracino A, Cicolini G. Nurses’ Knowledge, Attitudes and Practices on the Management of Clostridioides difficile Infection: A Cross-Sectional Study. Antibiotics. 2023; 12(3):529. https://doi.org/10.3390/antibiotics12030529
Chicago/Turabian StyleComparcini, Dania, Valentina Simonetti, Francesco Vladimiro Segala, Francesco Di Gennaro, Davide Fiore Bavaro, Maria Antonietta Pompeo, Annalisa Saracino, and Giancarlo Cicolini. 2023. "Nurses’ Knowledge, Attitudes and Practices on the Management of Clostridioides difficile Infection: A Cross-Sectional Study" Antibiotics 12, no. 3: 529. https://doi.org/10.3390/antibiotics12030529
APA StyleComparcini, D., Simonetti, V., Segala, F. V., Di Gennaro, F., Bavaro, D. F., Pompeo, M. A., Saracino, A., & Cicolini, G. (2023). Nurses’ Knowledge, Attitudes and Practices on the Management of Clostridioides difficile Infection: A Cross-Sectional Study. Antibiotics, 12(3), 529. https://doi.org/10.3390/antibiotics12030529